Edition:
India

aTyr Pharma Announces Q1 EPS Of $0.25


Wednesday, 13 May 2020 

May 12 (Reuters) - aTyr Pharma Inc ::ATYR PHARMA ANNOUNCES FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE ON ATYR1923 CLINICAL TRIALS IN PULMONARY SARCOIDOSIS AND COVID-19.ATYR PHARMA INC - TOTAL REVENUES WERE $8.1 MILLION FOR THREE MONTHS ENDED MARCH 31, 2020, CONSISTING PRIMARILY OF LICENSING REVENUE FROM KYORIN AGREEMENT.ATYR PHARMA INC - QTRLY EARNINGS PER SHARE $0.25.ATYR PHARMA INC - AS OF MARCH 31, 2020, ATYR HAD $49.8 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS.